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Nias Island., off the north-western coast of Sun:iatra, Indonesia, was one of the first locations in which chloroquine-
resistant Plasmodium vivax malaria was reported. This re.sistance is of particular concern because its ancient megalithic 
cu.lturc and the outstanding surfing conditions make the island a popular tourist destination. International travel [0 
and from the island could rapidly spread chloroqcine-resistanr strains of P. vivax across the planet. The threat posed 
by such strruns, locally and internationally, has led !O the routine and periodic re-assessment of the dli<:acy of 
antimalarial drugs and transmission potential on the island. Active case detection identified malaria in 124 (l7'!'~,) of 
no local residents whereas passiVe case detection, at the central health clinic, confirmed malaria in 77 (44%) of li3 
cases of presumed 'clinical malaria' . Inforrn,ed consenting volumecl'l> who had malarial parasj.taemias were treated, 
accor.ding [0 the Indonesian Ministry of Health's recommendations, wfth sl11fadoxine-pyrimethamine (SP) on day 0 
(for P. !alcipa",m) or with chloroquine (CQ) on days 0, I aJ;Id 2 (for, P. vivax) . Each voluntj!!cr was then monitored 
forclinicai and parasite response until day 28. Recurrent parasitaemia by day 28 treatment was seen in 29 (8."Y,.) of 
the 35 P. lalcipa"wl cases ·gh'en SP (14, II and four cases showing RI, RII and RIll resis.tance, respectively) . 
Recurrent parasitaemia was also observed, between day II and day 21, in six (21 %) of the 28 P. vivax cases given 
CQ. Although the results of quantitative analysis confirmed only low pTi;!valences of CQ-resistant P. v ivax malaria, 
me prevalence of SP resistance among the P. Ia/Cipa171111 cases v.>as among the highest seen in Indonesia. 
When the parasites present in the volunteers with P. /alcip(mml infections were genotyped, mut;ltiQ.ns associated 
with pyrimethamine resistance were found at high frequency in the dhJr gene but there was no evidence· of selection 
for sulfadoxine resistance in the d/zps .gene. 
Night-biting mosquitoes were surveyed by human landing collections and tested for sporozoite infection. Among 
the five species of human-biting anophclines collected, A.llopheles .~lIl1daiCII:< was dominant (68%) and thl: only species 
found to be infective - two (1 .2%) ef ) 67 females being found carrying P. vi~'ax sporozoites. The risk of malarial 
infection for humans on Nias was considered high because of the abundance of asymptomatic carriers, the reduced 
effectiveness of the available antimalarial drugs, and the biting and infection 'rates' of the local All. sulldaiClls. 
Malaria caused by Plasmodium vivax occurs 
over a broader geographical range than that 
caused by P. Jalcipanml and accounts for 
Reprint requests to: D. J. Fryauff. 
E-mail: fryaufJ'd':<:{!nmrc.navy.mil; fax: + I 3.0 I 3197545. 
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an immense burden of human suffering and 
illness. Chloroquine (CQ) has long been a 
safe, inexpensive and reliable treatment for 
P. vivax malaria but there are accumulating 
reports of treatment failure from such diverse 
locations as Papua New Guinea (Rieckmann 
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('I al., 1989) , Indonesia (Baird et al., 199 1b;
Schwartz el al., 1991 ), India (Garg el al.,
1995), and Guyan a (Craig and Kain, 1996) .
International travel, which has becom e mu ch
easier and m ore frequent over the last
four decades, may figure more importantly
in facili tating the geographi cal spread of
CQ-resistant P. ,·jvax (CQ RPV) than it
did in spreading CQ- rcsistant P. [alcipannn
(CQ RP F) in the 1960s.
D etailed , confirma tive stu dies of CQ RPV
have been relatively few, and efforts to track
the geographical spread of thi s pr obl em
have been largel y co nfined to the Indonesian
archipe lago - a popul ou s nation of so me
140,000 islands. Am ong all of th ese islands,
Ni as, in north- western Sum atra, drew early
attenti on as one of the first areas on the
planet th ought to be affec ted by C QRPV.
As Nias draws large numb ers of interna tional
tourists to its antiquities and surfers to its
waves, it was apparent that there was a great
risk o f resistant strains of malarial parasite
on the island bein g carried all over the globe .
Following on the case report of CQ RPV in
a repatriated Am erican tourist who acquired
his infection on Nias (Schwartz et al. , 1991 )
and confirmation of th is CQ RPV at the
Ce nters for Disease Control and Preventi on ,
in At lanta (Collins et al., 1992), in-vivo field
testin g of CQ sensitivity/res ista nce was co n-
ducted in early 1995 (Baird er al., 1996) .
The results of thi s first survey reveal ed CQ
resistance, to suppressive levels, in 33% of
the P. oiuax investigated , with parasitaemi as
recurring, within 19 days of supe rvised
therapy with CQ of good qu ality, in 14 %
(Baird el al. , 1996) . The ma in aim of the
present study, conducted 3 years later at the
same site, was to re-assess the sens itivity of
local P. viwax to CQ ill vivo, to det ermine
whe ther the frequ en cy and degree of CQ
resistance had measurably increased since the
first survey . At the same time, the efficacy,
in vivo, ofsulfadoxine- pyrirue thamine (SP) -
the seco nd- line therapy for uncomplicated
P. [alciparu nt infection - and the risk o f
malarial infection faced by a joint Am erican-
Indonesian military exercise planned for the
area were evaluated.
MATERIALS AN D M ET H O DS
Study S ites a n d Subjects
All-age malaria screenings we re co n-
du cted in five rural co mmunities (Lagundri,
Walondrawa, Botohil itan o, Hilinifaoso and
Hili amaetaniha) aro und the port of T eluk
D alarn , on the sou thern coast of N ias Island ,
between the Ju ly and September of 1998.
Ni as covers an area o f 56 25 km".
Passive case dete ction was also performed,
on a da ily bas is for 3 weeks (1-2 1 August
1998 ), through the health clin ic at Lagundri,
which covers all five study co mmunities.
M ost of the residents in the area have
occupations that are agricultural (rice culti-
vation, patchouli cultivation and perfume-o il
processing ) or associated with tourism . The
popularity of Legundri as an international
touristfsurfing des tination has created an
increasing demand for lodgin g, food and
othe r services. T ourist lodgings, restaurants
and housing for Indonesian families and
workers have proliferated on the land between
th e rice paddies, mangrove fore st and
beach, with faciliti es ranging from extremely
inexpensive/bas ic to we stern -style, 'five-star'
luxury . 1\ 1any yo ung tourists appear to
opt for very simple and affo rdable, longer-
term lod ging in traditional-style bungalow s.
Mosquito coi ls and untreated bednets are
widely used by both local resident s and tour-
ists. CQ, SP and quinin e are the respectiv e
first-, second- and third-line drugs for malaria
treatment in the Indon esian N ational Health
Serv ice and all are locally available in the
sho ps .
Sc reening and Enrolment
Indi viduals with un complicat ed , slide-
confirme d malaria who we re aged > 4 years,
abl e to swa llow pills, not pr egnant and who
had not consumed antimalarial drug s or
antibio tics in the previou s week were invit ed
to vo lunteer for malaria treatm ent in the
co ntext of a 28-day , in-vivo test. Written,
inform ed co nsent \vas ob taine d from eac h
volunteer or the volunteer's paren t/guardian .
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This consent included an assurance th at th e
volunteer agreed (1) to use no ot he r drug or
treatment but those provided and supervised
by th e research ers, (2) to submit to daily
sym ptom evalua tions and fingcrp ricks, and
(3) to submit to venipunc ture for cases of
P. uiuax that reappeared within 2 1 days of
receiving C Q . An enrolment of 38 1'. uiuax
cases was sought, based upon th e proportion
of CQ RPV previous ly reported ( 14% ; Baird
er al. , 1996), and th e aim to estimate the
new proporti on, with 90% confidence , to
be within 10 percen tage points of the true
value (Lcrneshowand T aber, 1991) . With no
previous measu re of clinical or therapeut ic
resistance to 51' in the local P. fakiparuni, it
was arbitrarily assume d that treatment failure
would occur in 25 % of cases (the critica l level
above whi ch an alternate treatment drug
wo uld be advised) . With 90 % confidenc e
and 10(% precision , th e desired samp le size
for testing the sensitivity of local P. falcipa rtnn
to SP was the n estima ted to be 5 1 infecti on s
(Lemeshow and T ab er, 199 1) . Individuals
with par asitaernia who de clined to enrol or
who were excluded from enrolme nt were
provided with free treatment and follow-up,
according to the local standa rd of care.
C h e m other a py a n d FoUow-up
Each sub jec t with P. cioax infection was
given a total of 25 mg CQ base (ResochinT.,, ;
PT Bayer, Jakarta, Indonesiaj/kg body weight,
as three oral doses of 10, 10 and 5 rug/kg
0, 24 and 4 8 h afte r rec ruitme nt (i.c, days
0, I and 2), resp ectively. The sub jects
with P. [alcipannn infection were eac h given
a sing le ora l dose of SP (Fansidar " ; Roch e,
Base l, Switzerland) - just on e tablet
(cont aining 500 mg sulfadoxine and 25 mg
pyrimethamine) if they weighed 15- 19.9 kg,
and 1.5, 2.0, 2.5 and 3.0 tablets if they
weighed 20-29, 30 - 39, 40- 49 and > 50 kg,
respectively. All the tabl ets were cons umed
after a sma ll snack of sweet biscuits and
water and each treatment was witnessed
by a member of the study team. Ph ysical
complaint s and axillary temperature \'vere
recorded and fingerprick blood sam ples (for
thi ck and thin blood smears) were co llec ted
on days 0- 4, 7, II , 14, 18, 21 and 28 and
also at any time of illness indi cative of ma laria.
The blood smc ars were stained with Giemsa
and exa mined by oil-immersion , light micro-
scopy (at x 1000 ) by a skilled microscopi st.
Each thi ck smear was exa mined for malarial
par asit es and only considered negati ve if no
parasit es were seen in 300 field s. Sexual-
and asex ua l-stage parasites were separately
counted against 200 leucocytes and each
count was then multiplied by 40 to give
an estimate of the number of pa rasitcs/ul
blo od (assuming eac h sub ject had 8000
leucocytcs/ul ) .
Al iq uots (I 00 ul ) of fingerprick blood
ob ta ine d on day 0, 2 and any time of
suspected treatment failure were co llected
onto filte r pap ers, labelled and air dri ed for
subseq ue nt use in ana lysing blood conce n-
tration s of CQ or th e parasite geno type
(sec below). Unre mi tti ng pa rasitae rnia or
reapp earan ce of asexua l parasites during the
28-day pe riod of the in-v ivo test consti tuted
a treat ment failure. The clinical sym ptoms
of malaria, with parasi taernia tha t did not
resolve following treatme nt or wh ich recurred
with parasitaernia, during the 28-day. follow-
up period, cons tituted a clinic al failure. In
acc ordance with nati onal health policy in
Indonesia, any CQ and SP failures observed
were given ora l qui nine for 7 days, as rescue
treatment . Cumulative indices of therapeu tic
( parasito logical) and clinical failure for ea ch
Plasmodium species and dru g trea tment were
calculated using the life- table method . The
parasitological respo nses of P. [alc iparum to
SP wen: gra ded, according to the standard
classification ofthe World Health O rgan ization
(1990), as S, RI , RlI or RIl l.
.I\ l ea su r c ln cn t of Blood C onccn tr a ti ons
of CQ
CQ and its pri ncipal metabolite , mono-
desethylchloroquine (D CQ) , were extracted,
from the filter-paper blots of the wh ole-
blood sam ples of those tre ated with CQ , so
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that their con centration s co uld be me asured
by HPLC (Patchen er al., 1983; Fryauff
et al., 1998) . T he persistence or reapp ear-
ance of asexual-stag e P. rioax parasites,
following full, supervised treatment and in
the presence of whole-blood co nce ntrations
of C Q + O CQ that exceeded 100 ng/m l -
the estimated minimal concentration effec tive
against CQ-se nsitive strains of this parasite
(Baird ct al., 1997) - was taken as con-
firmation of C Q resistan ce. [N ot e th at rhi s
definition may apply to post-treatment para-
sitae rnias arising from recrudescence, relapse
or re- infection (Baird et al., 1997) .}
Molecular J\\arkers of SP Resistance in
Plasmodiurn falciparurn
Parasite D NA was extracted, from the filter-
pap er blots of the whole-b lood samples of
those treated wi th SP, usin g 5%) Chelex- IOO
resin (Bio-Ra d Laboratories, Hercules, CA)
in distilled water and then purified through
an A72 1C minicolum n (Prornega, M ad ison
WI) . T he DNA was then amplified using the
nested-Pf.R method described by N agesh a
er al. (200 1), the appropriate po sitive and
neg ative co ntrols (to minim ize the risk of
contamination error in the first and second
rounds of the peR), and co nventional
primers and those speci fic for the resistan ce-
associated mutation s in the parasite's dhfr
or dhps genes (O urasingh et at. , 1998) . The
dhfr and dhps polymorphisms were ident i-
fied by RFLI' (restriction-fragment-length-
polymorphism ) ana lysis. The nest ed am pli-
ficat ion products of dhfr were digested with
NlaIIl, Tall, Tsp509 I , X1//1/1 and [)l'al ,
for discriminating the alleles at cod on s 16,
50, 5 1 and 164, whereas codo n 108 was
selectively cleaved with AIII I, RSI'I and SerF!.
The dhps PC R produc ts were digested with
iV/spA ll, Avail and Fok l fo r the identi-
fication of mutation s at codo ns 436,437 and
540 , B.<tU I and BsII for the iden tification
of those at codon 58 1, and AlztloI, BsaW!
and Agel for the identifi cation of those at
codon 6 13. As a control to munitor the end 0 -
nuclease diges tion, purified lambda DNA
(P rornega) was used in eac h RFLP exp eri-
ment. D igested produ cts were subjected
to electrop horesis on 1.5%- 3%, aga rose gel ,
or ultrapure agarosc gel (Progcn, Darra,
Au stralia) for enhanced resolution . The
PCR products of interest we re sequenced
according to published method ology (Wang
et al. , 1997a, b), to verify the RFLP results
and to identify any new mutation sites in the
dhfr and dhps products.
Assessm e n t of Transmission by
Mosquitoes
M osquitoes were captured outdoors in each
of the five study co mmunities, between
18. 00 and 23 .00 hours, as they landed on
the memb ers of a two-man team equipped
with flashlights and aspirators. Anophelines
were sorted, ident ified to species and stored
dried over silica gel until their heads and
thoraces could be tes ted in an ELIS A for
Plasmodium sporozoites (\Xlirtz et al., 1985 ,
1992). 1\ l onoclonal antibodies for Pifalcipan un
and the circumsporozo ite variants of P. v ivax
(VK24 7 and PV2 1O) wer e em ploye d in the
ELIS A. The ento mo logical data were used
to produce estimates of the man-biting rate
(bites/person-night) and the entomological
inoculation rate (infective bites/person-month)
assuming that the local mo squit oes only fed
durin g the collect ion period (18.00- 23.00
ho urs ) and that all the mosquitoes tha t
landed on the hum an bait wou ld have fed
on the bait.
RES U LTS
Malarra Prevalence by Location and
Age-group
All -age active case detec tion (ACO) ,
co nducted in July- Augu st 1998, identified
malarial par asitaern ia in 122 ( 17.2%) of the
710 people screened and revealed comm unity-
specific point prevalences ranging from 6%)
to 40 1% (T able 1) . M alarial parasitacmi as,
all of which we re low-density, were fou nd in
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TABLE I . The results of malaria p..1im-prt·i:ollclla screening by <1((i"", e.lSt' detection lUI 111.' unuhcru cwst of X i<1s Island,
Su matra. 1I1JOI.'s;d, ;/1 JI/~\L..S.·pt.:mbt·r / 998
>-:0. and (%) of subiects:
round positi ve for;
Location
Hilinifu oso
Lagundri
\'·a!ondrawa
Botohilitano
Hiliam acranih a
All rive study sites
Screened
258
1-13
1 0~
76
12Q
7 10
M alarial Pfasmo,JiwlI P/<Jw lOdillJ/t /)/,u lI/od;1/11/ j,l /dp,m llJl
para sites jiJldparum onl y ;: ;'/.',J.'( on ly and P. t ,It "../.I:
2-1 «() 7 (3) 17 ( 7) o (0)
9 (0) 0 (0 ) 9 (0) 0 (0 )
26 (25) i 3 (13 ) 13 ( 13) 0 (0 )
i 2 ( i O) Q ( 12) 3 (~) 0 (0 )
s: (·10) 29 (2 2) 20 (16) :2 (2)
122 ( 17.2) ')8 (R.2) b2 (8. i ) 2 (0. 1)
27 (8.6%) of the 314 appa rent ly asymp-
tomatic schoolchildren (aged 6- 13 years)
screened; six ( 1.9%) appeared to have pure
P. fa lciparunt infections whereas th e other
2 1 (6.7%) appeared to have pure P. ".'h'ax
infections. Passive case detection (PC D) , over
3 weeks in the Lagundri hea lth clini c, con-
finned malaria in 77 (44.8%) of the 173 cases
judged to be of 'clinica l malar ia' by local
healthcarc provid ers. The confirm ed cases
appea red to be infected with P. [alcipan nn
only (47 case s), with 1'. vicax only (28 cases)
or a mix ture of th ese two species (two cases) .
For both P. 'i..'i'iJa x and P. falciparum. th e
age distributions of those found pos itive
by ACD differed markedly for those found
positive by PCD (Fig. I). Children aged < 6
years, for example, accounted for 23 'Yo of
the infections found by ACD screening but
made up only SIX, of the confirmed clinical
malaria cases in the PC D (1'= 0.007 ) .
D espite the high freq uency of infection seen
in the children screened during the ACD
and the predominance of children in the
demography of the population (77% of the
residents of the study communities were
aged < 16 years at the tim e of enrolment),
adults (aged > 15 years ) made up 52 tX, of
the d iagn osed cases of clinica l malaria in the
ACD and accounted for 4 3% of those CO l1-
finned by mic roscop y in the PCD. In the
PCD, the olde r chi ldren and young adults
(i.e. those aged 6- 40 years) were twice as
likely to be confirme d positive by micro-
scopy as those who were younge r or olde r)
with a relative risk (RR) of 2.14 and corres-
ponding 95% confidenc e interva l (CI) of
1.30 - 3.54 .
E ffica cy of the CQ Treatment of
Ptasrnodiurn vivax Infec ti on
Illness at enro lment - most commo nly hea d-
ache (76%) , fever (68%) , malaise (44%),
nausea (·10%) an d muscle pain (24%) -
was reported by 26 of the 36 subj ects with
P. virax infection and eight were found to
be febrile (i.e. with an axillary temperature
~ 37 . 5 C). The cha racteristics of cases who
recei ved CQ treatment and remained avail-
able for all or most of follow-up peri od are
presented in Table 2. The corresponding
therapeutic and clinical responses are sum-
marized in Figure 2. Baseline ( pre-treatment)
concentrations of CQ + DCQ in three of
th e 30 subjects tested ranged from I 13-
639 ng/rnl, ind icating recent previou s treat-
ment and/or potentially resistant infec tions.
All parasitaernias declined rapidl y in response
to th e CQ trea tment given as part of thc
present study and cleared by 96 h . The mean
parasite-clearan ce time was 36.7 h, with CI
of ± 5.6 h . Illness aba ted in the majority of
the subjec ts by 72 h, with only three of 35
still reponing he ad ach e or nau sea at that
452 FRYAUFF ET AI..
SO
70 (u)
(J 60 -
~
=(J 50
=::
;!; 40
~
.. 300-
&: 20
10
0
0-5 6- 10 11-15 16-20 2 1-40 >40
(N=22) (N=34) (N=27) (N=23 ) (N=36) (N=3 1)
Age-group (years)
SO
70 (b)
u 60
~
=u 50
..
v: 40
e
=:: 300-
~ 20
10 .
o .
0-5 6-10 11 -15 16-20 21 -40 >40
(N=SO) (N=265) (N= 131) (N= I S) (N=83) (N=43 )
Age-group (years)
FI( ' . 1. The proportions of each age-group, screened by passive (a) an d actin: (0) C3<;C detection. found to be
infected with PI..umodium !<J1dl'.mwl ( .) or P. t'ii'l-!.' ( ).
lime . The first reappearance of asexual para-
sites following therap y and clearance was
on day 11. in two asymptomatic children.
These 1W O children, who had had 7280 and
> 40 ,000 tr ophozoites/ul and correspon d-
ing C Q + D C Q concentra tions uf 23 5 and
57 ng/ml on day 0 ( pre-treatment), bo th
had 160 trophozoitcs/ul on day I I Cr able 2)
and C Q + D CQ concentrat ions uf 0 and
270 ng/ml, respectively, on day 12. The on ly
ot her recurrent purasitaeruias de tec ted, on
day 18 in another four subjects. wen: all found
when those affected had low or undetec table
conce ntrations of CQ + D CQ in their blood .
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TABLE 2. SIIIIII1IJry of I1h' results of the 28-JolY. in- rico tests of the sensitivities of Plasmodi um falciparum ro
SIlIf"Jox;Il~'-pyn'mt'lhl1mille (SP) .m J P. vivax to d ,/onJi/lI;lle ( e Q)
Characteristic
x e . of subic cts
No. of mal es : femal es
1>AV-o ( I·ME-TREAT.\I E~"'T) VALL'""ES
;\t t'an age, (m edian) and (range] ( years)
~t can weight. (m edi an) and [range) (kg)
.\tean haemoglobin conc en tration and
(q ')% confidence interva l) ( g'dl)
Geometric mean parasitaemia and (ra nge)
(a..exual parasites 'ul )
CU ~lnJr.T I \· E I~CIDESCE OF PAR.",SITAE.\ lIA
Day 0
Day"
Day 7
Day 11
Day I-I
Day 18
Day 21
Day ~8
Me an time to recurrence and (range) (days)
MEAI' CQ + DCQ CONC E:-ITRATIONS ANn/OR ( RAKGE) (ng/m l)
Day 0
Day 2
Day 2R
Day of recurrence
39
22:17
15.6 (1 2) [6- 55 ]
33.8 (35) [15 -571
9 .7 (9 .2- 12.2)
100 3 (40-80, 000)
0 .00
0 .2 3
0 .34
0 .59
0 .69
0 .69
0 .73
0.76
11.0 (·1-28)
36
22 : 1-1
1-1 ( I I) 1-1 - 501
29 . 3 (27. 5) (12-19)
9.5 (9. 2-Q.R)
-18 3 (-10- -10, 000)
0 .00
0 .00
0.00
0.06
0.20
0.20
0.20
0.20
17.0 (12 - 19)
- (0- 633)"
568 (2 16- 1169)
38 (0-3 15)'
- (0- 270)*
* Blood samples collected from 30 of the subjects at enrolme nt revea led that seven of th e 30 th en had detectable
blood concentrat ions (22- 6 33 ng-ml ) ofCQ plus its metabolite rnonod cscth ylchloroquine (D CQl , and that three
of th e seven had > 100 ng CQ + DCQ'ml.
"Seven of th e 22 sub jects chec ked had detectable blood concentrations of CQ +- D CQ on day 28, three having
> 100 ngml at that rime .
t O ne of the six subjects checke d on th e- day of recurrence had > 100 ng CQ + DCQ'm l.
Efficacy of the SP Treatment of
Plasrnodiurn folciporum In fection
Symptom s - most commonly headache
(94%) , fever (8 1%), malaise (72%), nausea
(56%), and vomiting (37%) - were reported
at enrolment by 33 of th e 39 subjects with
P. falcipa nnn infection although only 1-1
(36%) were found feb rile at that time. The
geometric mean (G :\ I) P. falcipannn pa ra-
sitacmia before trea tment (on day 0) was 10
times higher [han the corresponding P. riocx
parasitaernia (T able 2). In general, the
clinical and therapeut ic resp on ses to SP were
poor. At the day-3 (72 h) follow-up, fever
had resolved in 13 of the 14, initially febrile
cases but 47 % an d 24 % of all those given
SP were still complaining of headache and
malaise, respectively. Asexual pa rasitaernias
declined by > 25 % within 48 h of treatment
in 34 cases (of the 38 providing the relevant
data) and had clea red by day 4 (96 h) in
28 of the 39 cases. U nremitting R1II- or
Rll-typ e responses within 7 days of trea t-
ment characteri zed, respectively, four (I 1%)
and I I (29%) of the SP treatments. Two of
the subjects treated with SP withdrew from
follow-up and th ree others were di s-enrolled
between days 7 and 11 because of intercurrent
P. V iVdX infection . F igu re 2 illustrat es the
cum ulative inci dence of clinical and the ra-
peut ic failu res over th e 28 days following
S P trea tment. T he majority (24/29) of the
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FIG . 2. Profiles of the clinical and pa rasitological responses obs erved in the sub jects post-treatment . "I1H.' lines
plotted show the proportions ofsubje cts who wen.' symptom atic (L) or parasitacmic ( _) after their P/tJsl1todill1J/
!l1ld p,mIlJl infections were [rcated with sulfudo xine-pvrimcthammc (on da y 0) and the corresponding pr oportions
of subjects wh o wer e sym pto m atic ( . ) or pamsitaemic ( ) aft er th eir P. vinax infections were treated with
chlo ro q uin e.
the rapeutic failures occ urred during the first
11 days, with treatment success achieved in
only six of the 35 ease s wh o provided suffi-
cient data . The frequency of gam etocyte
ca rriage and th e G l\1 densit y of th e gamcto-
cytaernias observed inc rease d progressively
over th e firs t 7 da ys following SP trea tment
(F ig. 3) . Retrospective mole cular ana lyses,
to determine wh ether allelic mutations in th e
dhps and dhfr genes of the infecting parasit es
could have predi cted SP treatment outcome,
were performed on 27 cases wh o had be en
graded S, RI , RII or RIll . Sequencing of the
peR products revealed that dhps codo ns
43 6, 437, 581, and 6 13 were all normal
wild -type and that mu tati on s in th is gene
had not arisen or been selec ted for. Although
sequencing of dhfr identified point m utation s
only at codons 108 and 59 , th ese m uta tions
were dete cted in 26 (96%) and 2 1 (78%)) of
the 27 cases, respectively, with 20 cases eac h
having the double mutati on . There was no
apparent asso ciation between the frequen cy
or pa tte rn of these dhf r mutation s and th e
in-vivo resp on se Cr able 3); the double muta-
tion, for example, was seen in each of th ree
sensitive (S) infecti on s as well as in th ree
RIll treatment failures. The sing le infecti on
that was wild-type at all dlifr codo ns appea red
to recrudesce on day 11 post-treatment . A
comparison of the day-O and day-7 dhfr
profiles of each of nine cases demon strating
RIl- or RIll-type resistan ce showed the
Arg59 and Asn I08 double mutati on at both
tim e-poin ts. Quinine rescu e ther ap y was
successful fo r all of the SP treatment failu res.
Mala ria Transmission Potential
H uman-biting A nopheles accounted for 25 1
( 12.5%) of the 2003 night-b iting mosquitoes
captured during 2 16 person-hours of co llec-
tion. Five ano pheline spec ies, including three
kno wn to be vectors of P. fal ciparum and/or
P. uiuax - A nopheles sundaicus (Rodcnwalt) ,
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of (detectable) gametocytaemia ( - ) and the geome tric mean densities of P. [alcipartnn garnetocytcs ( . ) amo ng
[he garnctocytacmics.
A n. sinensis (W iederuann) an d All. tessellatus
(T heob ald) - we re ide ntified. Anopheles
sundaicus accounted for 68 % of the 245
Anopheles identified and tested and An. sinensis
for 18%. Collectively, Anopheles biting rates
ranged from I - 20/person-night, with All.
sundaicuspredominant in 11 ofth e 18 location s
surveyed and All. sinensis predominant in six
inland locations.
Only [\\'0 mosquito es - both All. sundaicus
infec ted with the Pv210 variant of P. "im x -
were found to be carryi ng spo rozoi tes. The
sporozoi te 'rate" was therefore 0.8 % for
all of the Anopheles tested and 1.2% for
th e All. sundaicus. Since th e mean biting
rate for all Anopheles was 6.8 bit es/person-
night, the entomo logical inoculation rate was
(conservatively) estima ted at 1.6 infective
bites/person -m onth (T able ~) .
DISC USSION
The princ ipal aim of the prese nt study was
to initiate periodic, in-vivo re-testing, to de tect
any cha nge in th e fre que ncy of C Q Rl'V at
an Indonesian site where th is tra it had been
first recogni zed and co nfirmed (Schwartz
er al., 1991 ; Collins <'I aI., 1992 ) . The pre-
sent investigation, cond uct ed 3 years after
the first survey for C Q RPV on N ias (Baird
et al. , )996), does not provide any evid ence
of such a change . Althou gh the present
results inclu de clear indication s of P. 'V;V QX
resista nce to both suppressive and thera-
peu tic co ncentra tions of CQ, th ey show no
grea ter freq uency of such resistance than that
reported for the same site in 1995 (Baird et al.,
1996) . The C Q-lOlerant or C Q-resist an t
P. cicax troph ozoitcs observed in th e present
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·111~· cod ons of isolates collected from this pa tient on da y (1 and the da y of recurren ce were compared (and found
to be ident ical ).
'J'ABLE :L 'J 'h ~' pveoatcnces lIt" ill/~'aioll >:1..'1[il ma larial sporozoite, man-biting r!,lUS (.\ IBR) , ami estimated cutomotoeical
inoculation rates ( E IR) for f h ~' Anopheles III 11S41';f/)~'S collected 011 .\ 'ius /slalld , S umatra
Sporozoite ELISA
S pec ies
.-111l1phdes f<'ss.:lla flut
/ 111. k llchi
All. mmfvrdi
A'l . s illol.\' i~t
All. wlldu iclISt
~IRR' EIR'
No. rested No. an d ('Yo) po sit ive (bites-p erson -n ight) (infective bircs-person-mourh)
(, 0 (il) 0.2 0
I J 0 (il ) 0 ." 0
I ·l 0 (0) 0..1 0
"; 0 (0) 1.2 0
167 2t ( 1.2) -1.6 1.6
..Assuming all bit es occur each night on ly during the 'i-h peri od ( 18 .00- 2 3.00 hours) when the land ing catches
were made and that 311 landing rno squirocs would ha w bit ten th e human bait . For [he .\ l HR, a month was taken
to be 28 da ys,
t C onfim1cd vec tor (If at least \1Ot: I Y.,WIIOJ i ll ll/ species tha t infects h umans .
t Both Infected with PillS/lIl ll-filllll »ico».
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study were also found in the pre sence of
C Q + D CQ conc entrat ions similar to those
detected in 1995 (Baird 01 al. 1996).
It is unclear wh y, given the apparently
equ al se lective pressure applied world-wid e
to P. viuax and P. [alcipurnnr by CQ use and
mis-u se, CQRPV is much less common than
C Q RPF. This may be related to the obse r-
vation that CQ-scnsitive P. oivax can be killed
by a dose of CQ that is only abo ut a qu arter
of th e dose needed to kill CQ-se nsi tive
P. [alciparum (Berliner 01 aI., 194 8). The CQ
resist an ce in P. falciparum has been shown
to be cent rally depe ndent up on a po int
mutation (K76n in a single gene (pf m )
coding for a transpo rt protein in membrane
of the parasit e's digestive vacuo le (F idock
(1 al., 2000). This point mutati on was pre-
sent in eve ry clinical case of CQ RPF studied
in M ali by Djimde 01 al. (200 1) and in 93%
of the C Q RPF cases studied in Papua,
Indonesia, by Maguire 01 al. (200 I). Alth ough
a gen e ortho log present in P. uiuax ( p'vcg I 0)
is remarkably similar to pfcn in terms of its
position , com position and struc ture, no point
mutati ons th at distinguish CQ-sen sitivc and
C Q -rcsiswnt ph enotypes of P. ciua» have
been found in pucgl O(N om ura Cl al., 2001 ) .
The apparent molecular divergence in the
C Q-resis tance strategies of P. falciparum and
P. viuax is in contrast to the com mo n mech-
anism of ant ifolate resistan ce seen in all th e
mal ari al parasites of rodents and humans
investigated (D e Pecoulas ct al., 1998;
Carlto n 01 al., 200 1) .
The present results do no t warrant
increased concern about CQRPV on Nia s
or more frequent monitoring of CQRPV on
the island. H owever , the poor clin ical and
therapeutic effects of SP on local Pi fa lcipannn
and the almost ubiquitous occurrence of dhfr
mutat ions conferring pyrimethamine resist-
ance in these par asites arc worrying. The
frequency of SP treatment failure obse rved
on N ias is among the highe st reco rded in
Indonesia - even excee ding those recorded
on Papuan Indonesia (Baird et al., 1991a;
Tjitra 01 al., 1997; N agesh a 01 al. , 200 1) -
and meets the World H ealth Organ izat ion's
criterion for a cha nge in the an tima laria l
drug used (W H O , 1994 ) . All 74 cases fro m
central and nonhero Sumatra wh o were
tested i ll V itl{l between 1981 and 1985
dem on strated sens itivity to SP , although
in-vitro testing over the same period and in
the same locations sho wed SP resistance in
28 of 38 isolates (T iitra 01 al., 1997). A rapid
ch ange in the sens itivity of P. [alcipa rum
to pyrimethamine and SP was obse rved in
north- east ern Papuan Indonesia (H offman
01 aI., 1985 , 1987; Baird 01 al. , 199I a),
altho ugh resist ance to pyrime tha mine and
cross -resistance to proguanil evolved early
and progressed rapidly there, as a res ul t of the
mass dist ribution of pyri me rha mi nizcd salt
in 1959-1 960 (M cuwissen, 1961 ) . Interest-
ingly, th e ca mpa ign to di stribute and pro-
mote the use of th is med icat ed salt mark edly
reduced the preval en ce of P. vivax and
P. nratariac malaria, with pyrimethamine
remaining effective as both a treatment
and prophylactic agains t P. cioax at a time
of increasing resistance in P. [alcipan tm
(Mcuwisscn, 1964 ). There appears to be no
record of the use of pyrirnetharninizcd salt
on Xias. Resistan ce to CQ in P. faiciparum
and high freq uenc ies of gametocyte carria ge
in chi ldren pr ompted health ollicials and
resear chers to ado pt SP plus primaquine for
the routine trea tment of malaria in coastal
north Sumat ra during a com m uni ty health
project in 1985 -1 989. Alth ou gh th is co-
operative (Indonesian- Japanese) programme
led to a marked reduction in the prevalen ce
of P. falcipanun infection, there was littl e
change in P. oioax, despit e the combine d usc
of chemo the rapy, bednets and larvi ciding
(Doi 01 al., 1989) .
The results of th e present analyses of dhfr
and dhps in P. falciparum from Nia s ar e
singular in dem onstrating no evide nce of any
mutati on in the dhps gene associated with
SP resistance. The non-involvemen t of dhps
point mutat ion s appears not to have been
reported before in any area were the re were
such high freq uencies of SP treatment failure .
The dhps mutat ion at position 437 is a com-
monly reported marker of sulfadoxine pressure
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and ' v·as detected in all the P. fulcipannn
isolates, from nearby M alaysia, tested by Cox-
Sin gh et al. (200 I) . Analysis of dhfr from
P. falcip arum collec ted in Papuan Indonesia
ide ntified the A SH 108 mutation in 8 1% of
malaria-naive immigrants (N agesha et al. ,
20 0 I) and 62%, of malar ia-immune na tive
Papuan s (H . S . Na gesha, unpubl, obs .) ;
both significant ly lower proportions tha n the
frequen cy of Asn I08 in the present samples
from N ias (96%) . In co ntras t to th e pre-
sent results frum Ni as, the P. [alciparnni in
the sym pto matic, non-immune immigrants
from Papuan Indon esia com monly expressed
point mutation s in the dlips gene at codons
4 37 (83%) and 54 0 (47%) , altho ug h " lips
mutation s (at positi on 437 in 24%, an d at
pos itio n 54 0 in 5%) were seen far less
frequently in th e parasites from th e asym p-
to matic infections in the native Papuans
(H . S. Nagesha, unpub!. obs.). It see ms
possible that dhps mutation s pla y a re lat ively
small role in SP resist an ce (or co nfer a
relatively sma ll adva ntage in terms of the
pa ras ite's survival) under condit ions of low
transmi ssion int en sity.
A recently reconside red problem is the
potential fo r 5P treatm ent to exacerbate
co m m un ity levels of P. [alcipartnn t ra ns-
mi ssion, by elevat ing the prevalence and
inten sit y of ga rnctocyta cmias. This d is-
advantage of SP ha s alread y been reported
in Asia (Tin and Nyunt Hlaing, 1984;
Marworo "I al., 1986) and much debated
(Itt iravivongs et al., 1984 ; Strickland et al.,
1986; Baird el al., 199I e) . Among the non-
irnrnuncs in north- eastern Papuan Ind on esia
who were given SP in 1996 -1 998, as a
resc ue treatmen t following CQ failure, the
prevalenc e of garnetocytaernia rose fro m 0%
to 43 % within 7 da ys, with the GJ\\ int en sity
(among th ose who were gamerocy tae mic )
peaking, on day 14, at 199 gam etocytes/ul
(C I = I 53- 277lfLi ; unpub!. obs. ) . H owever,
the gametocyte resp on se obse rved in N ics,
where the prevalence of gam ctocytaem ia rose
from 26 % to 7 3%, within 7 da ys and the
peak G i\\ int en sit y was 44 5 gamctocytes/u l
(C I = 282-700Ipl) on day 7, was sign ificantly
higher. In compariso n, on an isolated island
off north- western Papuan Indon esia, whe re
all the P. [alcipan un ap peared Sl'-sen sitive,
ga rne tocy tes wer e see n in only four of 40
cases between days 0 and 7 and in only 12 of
288 smea rs prepared later in the follow-up,
and then always at low densities (Fryauff et al.,
1999). No atte m pt was made to determ ine the
viabili ty and infectivit y of the game tocytes
in the elevated gamctocy tae rn ias appa rently
induced by SP treatmen t on Ni as, but these
gametocyt es may well be viabl e and similarly
resist ant to the spo ronticidal activity of 5P
(Butcher, 1997 ; Robert et al. , 2000) . T he
early ap pearance of the garnc to cytacrnias,
soon after SP treatment , has been taken as
an ind ication tha t the gametocytcs seen, man y
of which arc immature and non-infective,
ha ve not been induced by the treatmen t but
merely mobilized or re-di stributed from sites
whe re they have been seques te red (T argett
et al., 200 1) . Whil e the pyrimethamine-
me di ated mobiliza tion or development of
ga rnetocytc s (C hurmongkonkul et al. 1992)
on Ni as may h ave been enhanced by muta-
tions in the d/~fr gene , it also see ms possible
that the absence of mutations assoc iated
with sulfadoxinc resistance in dhps m ay
have somehow stim ulated gamctocytogenes is
(Butcher, 1997; Hogh el al. , 1998).
T he present dem onstration of P. uioax
sporozoites in All. sundaicns and th e domi-
nance of this mosquito species among the
man -bi tin g ano phelincs co llecte d were not
un expected in the coas tal study area. Anopheles
sundaicus is conside red to be the dominant
vec to r of both P. oioax and P. [alcipanun
over m uch of coas ta l Indon esia (Imai t!t al. ,
1988) and is respon sible for the per sisten ce
of malari a along the sout hern coast of Java
despite the successful elim inat ion of malaria
from most of this island (Atm oesodiono et al.,
1992). A nopheles tesselatus is a confirmed vector
of P. on-ax and P. fukipa nnn in south ern Asia
(G arnage-M end is et al. , 199 3) and was pre-
vious ly the only confirmed vec to r of malari al
parasit es on Ni as (Indones ian M inist ry of
H ealth, u npub!. obs .). Anopheles sinensis
is a co m mon, primarily zoop h iliclexophilic
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an opheline of eastern Asia th at is rep or tedly
refractory to most P. falcipanun infection s
(Somboon el al., 1994; Ron gsriyam et al.,
1998). The potential for P. uiuax trans-
mission by Au. sinensis derives mainly fro m
the high de nsities th at population s of this
species ca n attain CRee et ol., 200 1). T he
present co llect ions of mosqu itoes on N ias
we re limited in sampling time, season
and locat ion and therefore probably biased .
ANopheles tcsselatus, An. sinensis and ot he r
freshwa ter-breeding an ophclincs undetected
in the brief survey on coasta l Nias may
be more ab un dant inland, whe re they may
play a more import ant role in malarial
tr ansmi ssion .
In summary, act ive case de tection identified
large numbers of asymptomatic infections
and garnetocytae rnias, predo minant ly amo ng
young children, in the rura l population of
southe rn, coa stal Nias. No evidence was
found of increasing resistan ce to C Q in the
local P. cieox at th is con firmed focus of
CQ RPV but th e results of in-vivo testing
de mo nst rated poor therape utic an d clin ical
respon ses to SP in P. falciparuni. There was
a high frequen cy of mutation s in the dhfr
gene that arc associated with pyrim ethamine
resistance in P. falciparum, but no sign of
selection pressure by sulfado xine in the dhps
gene. In add ition to its poor clin ical perform-
ance, 5 P ap peared to increase th e frequen cy
and intensi ty of garnetocytacmias, po tentially
heightening malaria transmission and disease
risk in the area. Alth ough CQ still affords
goo d treatment efficacy aga inst P. virax
on Nias, the use of 51' alone in the treat-
ment of P. falcipanun on th e island sho uld
be stro ngly discouraged . SP sho uld on ly be
used in combina tio n with a rapidly acting
and garnetocytocid al arre misinin derivative
(Kumar and Zheng, 1990; Price el al.,
1996) . In Africa, the cost of treatment
with a combina tio n of SP and artesuna te is
current ly reported to be U.S.$ 1.30 more
th an th e cost of SP alone (which is be low
U.S.$0. 20) and beyond the reach of 1110st
of th ose with m alaria (Vick, 2002). In
Indonesia , however, the cos ts of SP p lus
artcsuna te may be man ageabl e, especially if
they could be reduced greatly by in-co untry
production of Artemisia a111wa. Even tho ugh
most isolates of P. falcipa nun from Nias
appear resistant to treatment with CQ an d
SP, th e use of a combination of C Q and SP
might offer some ad vantage over the use
of either C Q or SP as a first-line strategy
against unco mplicated, P.Jalciparum ma laria
(Wins ta nley, 200 1) . T ourist s and trave llers
to Nias arc advised always to usc bc dncts,
topi cal mosquito repellents and effec tive
chemoprop hylaxis, to reduce the ir risk of
acquir ing malaria on the island (and of
carrying multi -resist ant strains to other
region s).
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